Clinical Study

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma

Table 4

Number of complications between the two groups.

ComplicationsGroup IGroup II

Pancreatic fistula79
Intraperitoneal hemorrhage34
Lymphorrhea56
Small bowel infarction22
Diarrhea45
Pulmonary embolization21
Atelectasis32
Delayed gastric emptying58

Total 3137